Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Non-cash Items (2016 - 2022)

Historic Non-cash Items for vTv Therapeutics (VTVT) over the last 8 years, with Q1 2022 value amounting to $2.5 million.

  • vTv Therapeutics' Non-cash Items rose 1739.22% to $2.5 million in Q1 2022 from the same period last year, while for Mar 2022 it was $2.5 million, marking a year-over-year increase of 1739.22%. This contributed to the annual value of $2.9 million for FY2021, which is 5696.8% up from last year.
  • vTv Therapeutics' Non-cash Items amounted to $2.5 million in Q1 2022, which was up 1739.22% from $2.9 million recorded in Q4 2021.
  • vTv Therapeutics' Non-cash Items' 5-year high stood at $2.9 million during Q4 2021, with a 5-year trough of $1.0 million in Q1 2018.
  • In the last 5 years, vTv Therapeutics' Non-cash Items had a median value of $1.8 million in 2020 and averaged $1.7 million.
  • In the last 5 years, vTv Therapeutics' Non-cash Items skyrocketed by 17709.3% in 2018 and then soared by 795.94% in 2019.
  • Over the past 5 years, vTv Therapeutics' Non-cash Items (Quarter) stood at $1.2 million in 2018, then increased by 7.29% to $1.3 million in 2019, then soared by 46.24% to $1.9 million in 2020, then surged by 56.97% to $2.9 million in 2021, then fell by 13.8% to $2.5 million in 2022.
  • Its Non-cash Items was $2.5 million in Q1 2022, compared to $2.9 million in Q4 2021 and $2.2 million in Q3 2021.